WO2023010682A1 - Antibody capable of detecting nicotiana tabacum agglutinin protein, preparation method therefor and application thereof - Google Patents
Antibody capable of detecting nicotiana tabacum agglutinin protein, preparation method therefor and application thereof Download PDFInfo
- Publication number
- WO2023010682A1 WO2023010682A1 PCT/CN2021/123450 CN2021123450W WO2023010682A1 WO 2023010682 A1 WO2023010682 A1 WO 2023010682A1 CN 2021123450 W CN2021123450 W CN 2021123450W WO 2023010682 A1 WO2023010682 A1 WO 2023010682A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- emulsion
- immunization
- animal
- lectin protein
- antigen
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims description 59
- 101710186708 Agglutinin Proteins 0.000 title abstract description 8
- 101710146024 Horcolin Proteins 0.000 title abstract description 8
- 101710189395 Lectin Proteins 0.000 title abstract description 8
- 101710179758 Mannose-specific lectin Proteins 0.000 title abstract description 8
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 title abstract description 8
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 title abstract description 8
- 244000061176 Nicotiana tabacum Species 0.000 title description 3
- 239000000839 emulsion Substances 0.000 claims abstract description 42
- 230000003053 immunization Effects 0.000 claims abstract description 42
- 238000002649 immunization Methods 0.000 claims abstract description 42
- 241001465754 Metazoa Species 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000011091 antibody purification Methods 0.000 claims abstract description 5
- 241000208125 Nicotiana Species 0.000 claims description 56
- 102000004856 Lectins Human genes 0.000 claims description 52
- 108090001090 Lectins Proteins 0.000 claims description 52
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 45
- 239000000872 buffer Substances 0.000 claims description 39
- 239000000427 antigen Substances 0.000 claims description 31
- 102000036639 antigens Human genes 0.000 claims description 31
- 108091007433 antigens Proteins 0.000 claims description 31
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 239000002671 adjuvant Substances 0.000 claims description 16
- 238000004587 chromatography analysis Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000004471 Glycine Substances 0.000 claims description 8
- 150000001413 amino acids Chemical group 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000010254 subcutaneous injection Methods 0.000 claims description 5
- 239000007929 subcutaneous injection Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000000703 high-speed centrifugation Methods 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- 239000000910 agglutinin Substances 0.000 abstract description 4
- 238000002331 protein detection Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 13
- 238000012546 transfer Methods 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000002523 lectin Substances 0.000 description 7
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention relates to the technical field of tobacco lectin protein detection, in particular to an antibody capable of detecting tobacco lectin protein and its preparation method and application.
- Tobacco lectin (Nictaba, Nicotiana tabacum agglutinin) was isolated from tobacco leaves for the first time in 2002, and it is an effective substance that can control various diseases and insect pests. Although there are very few related studies in China at present, a new research direction of using Nictaba as a carrier and using tobacco natural products for pest control is slowly being formed abroad. Tobacco lectins are distributed in various parts of the tobacco plant; the content of Nictaba is higher in the leaves, however, its presence is not detectable in all tobacco varieties.
- the present invention firstly provides a method for preparing an antibody capable of detecting tobacco lectin protein; the antibody prepared by the method has high specificity for detecting tobacco lectin protein, and can be used for detecting tobacco lectin protein, for The detection of tobacco lectins provides a new way.
- a method for preparing an antibody capable of detecting tobacco lectin protein comprising the following steps:
- Preparation steps of emulsion 1 mix antigen, Freund's complete adjuvant and PBS (specifically 0.01M PBS) to prepare antigen-containing emulsion 1;
- Preparation steps of emulsion 2 mix antigen, Freund's incomplete adjuvant and PBS (specifically 0.01M PBS) to prepare antigen-containing emulsion 2;
- the immunization step includes injecting the emulsion 1 into the animal to immunize the animal for the first time; after the first immunization, injecting the emulsion 2 into the animal to immunize the animal for the second time; After the immunization, inject the emulsion 2 into the animal to immunize the animal for the third time; and/or after the third immunization, inject the emulsion 2 into the animal to immunize the animal for the fourth time;
- Antibody purification step taking animal serum and purifying the antibody from the serum to obtain the antibody that can detect tobacco lectin protein;
- amino acid sequence of the antigen in emulsion 1 and emulsion 2 is shown in SEQ ID NO: 1.
- the dosage ratio of antigen, Freund's complete adjuvant and PBS is 300-500ug: 1mL: 1mL;
- the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 300-500ug:1mL:1mL.
- the dosage ratio of antigen, Freund's complete adjuvant and PBS is 400ug:1mL:1mL.
- the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 400ug:1mL:1mL.
- the amount of injected antigen is 40-60ug.
- the amount of injected antigen is 50ug/bird.
- the injection mentioned in the immunization step refers to subcutaneous injection.
- the animals in the immunization step are mice.
- the time for the first immunization is 2-3 weeks; the time for the second immunization is 2 weeks; the time for the third immunization is 1 week; the time for the fourth immunization is 1 week.
- Emulsion 1 and Emulsion 2 to immunize mice with the above steps four times, higher titers of antibodies that can detect tobacco lectin protein can be obtained.
- the antibody purification step specifically includes:
- the inventors have shown through a large number of studies that: high-purity antibodies that can detect tobacco lectin protein can be obtained by using the above chromatography column method.
- the PBS buffer containing citric acid described in step (3) refers to the PBS buffer containing 0.1M citric acid
- the PBS buffer solution containing citric acid and glycine refers to the PBS buffer solution containing 0.7M citric acid and 0.3M glycine.
- the composition of the PBS buffer plays a crucial role in the preparation of high-purity detectable tobacco lectin protein antibodies; when using PBS buffer containing 0.1M citric acid for washing When deactivated, high purity and high titer antibodies that can detect tobacco lectin protein can be obtained by enrichment. Further studies have shown that: when eluted with PBS buffer containing 0.7M citric acid and 0.3M glycine, antibodies that can detect tobacco lectin protein with higher purity and higher titer can be enriched.
- the present invention also provides an antibody capable of detecting tobacco lectin protein prepared by the above preparation method.
- the antibody capable of detecting tobacco lectin protein has the amino acid sequence described in SEQ ID NO: 2 or/and SEQ ID NO: 3.
- the present invention also provides an application of the above-mentioned antibody capable of detecting tobacco lectin protein in detecting tobacco lectin protein.
- the present invention prepares for the first time an antibody that can detect tobacco lectin protein; the antibody that can detect tobacco lectin protein has high specificity for tobacco lectin protein; therefore, the present invention can be used
- the antibody that can detect tobacco lectin protein is used to detect tobacco lectin protein; the antibody that can detect tobacco lectin protein according to the present invention is successfully prepared, which provides a new detection approach for the detection of tobacco lectin protein; in addition,
- the antibody capable of detecting tobacco lectin protein prepared by the method of the present invention also has high purity and titer; and the method is simple to operate and low in preparation cost.
- Example 1 Preparation of an antibody capable of detecting tobacco lectin protein
- the amount of antigen injected was 50ug/monkey; the time of the first immunization was 3 weeks; the time of the second immunization was 2 weeks; The time for the third immunization is 1 week; the time for the fourth immunization is 1 week;
- the antibody that can detect tobacco lectin protein can be obtained by lyophilizing the liquid.
- the antibody capable of detecting tobacco lectin protein has the amino acid sequence described in SEQ ID NO:2.
- Antigen coating Dilute the antigen with coating solution to the specified concentration (1ug/ml if not specified separately), add 100 ⁇ L/well into a polystyrene 96-well reaction plate, and place at 4°C overnight.
- Blocking add 200 ⁇ L/well blocking solution, and place at 37°C for 2 hours.
- Washing wash 5 times with washing liquid.
- Stop reaction, colorimetry add 50 ⁇ L/well stop solution. The color turns yellow; use a microplate reader to measure the absorbance of each well at 450 nm.
- the absorbance value in the measurement well of the test sample is more than 3 times the average value of the negative control well, which shows that the antibody prepared by the present invention that can detect the tobacco lectin protein is positive; and has a higher titer.
- Embodiment 3 Western Blot experiment
- separating gel solution with a concentration of 15%: add 2.3ml of deionized water, 5ml of 30% acrylamide, 2.5ml of Tris with a pH of 8.8, 100 ⁇ L of 10% ammonium persulfate, 100 ⁇ L of 10% SDS, and 6 ⁇ L of TEMED (add TEMED After that, the separating gel starts to polymerize immediately, so it should be mixed immediately and quickly);
- blocking solution is 1% casein or 2% OVA
- Example 1 reacts with the tobacco lectin protein and does not react with the empty vector, and the blank control group does not react with the tobacco lectin protein; this shows that the antibody prepared in Example 1 has no effect on tobacco agglutinin. Proteins are specific.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to the technical field of nocitiana tabacum agglutinin protein detection, and specifically discloses an antibody capable of detecting nocitiana tabacum agglutinin protein, a preparation method therefor, and an application thereof. The preparation method comprises the following steps: a preparation step for emulsion 1; a preparation step for emulsion 2; an immunization step, comprising: injecting the emulsion 1 into an animal body to carry out first immunization on the animal; once the first immunization has ended, injecting the emulsion 2 into the animal body to carry out second immunization on the animal; once the second immunization has ended, injecting the emulsion 2 into the animal body to carry out third immunization on the animal; and/or once the third immunization has ended, injecting the emulsion 2 into the animal body to carry out fourth immunization on the animal; and an antibody purification step. The antibody prepared by the method has high specificity for measuring nocitiana tabacum agglutinin protein, and can be used to detect the nocitiana tabacum agglutinin protein, thereby providing a novel way to detect nocitiana tabacum agglutinin.
Description
本发明涉及烟草凝集素蛋白检测技术领域,具体涉及一种可检测烟草凝集素蛋白的抗体及其制备方法和应用。The invention relates to the technical field of tobacco lectin protein detection, in particular to an antibody capable of detecting tobacco lectin protein and its preparation method and application.
烟草凝集素(Nictaba,Nicotiana tabacum agglutinin)于2002年第一次从烟草叶子中被分离出来,是一种可防治各种病虫害的有效物质。虽然目前国内相关研究极少,但在国外却正在慢慢形成以Nictaba为载体、利用烟草天然产物进行病虫害防治的新研究方向。烟草凝集素在烟草植株中各个部位都有分布;叶子中Nictaba的含量更高,然而并不是在所有的烟草品种中都可以检测到它的存在。Tobacco lectin (Nictaba, Nicotiana tabacum agglutinin) was isolated from tobacco leaves for the first time in 2002, and it is an effective substance that can control various diseases and insect pests. Although there are very few related studies in China at present, a new research direction of using Nictaba as a carrier and using tobacco natural products for pest control is slowly being formed abroad. Tobacco lectins are distributed in various parts of the tobacco plant; the content of Nictaba is higher in the leaves, however, its presence is not detectable in all tobacco varieties.
为了更好的将烟草凝集素用于病虫害防治;对于植物中是否含有烟草凝集素的检测是十分必要的;但是目前缺乏专门的检测烟草凝集素的方法。In order to better use tobacco lectin for pest control; it is very necessary to detect whether tobacco lectin is contained in plants; but there is currently a lack of a specific method for detecting tobacco lectin.
发明内容Contents of the invention
鉴于此,本发明首先提供了一种可检测烟草凝集素蛋白的抗体的制备方法;由该方法制备得到的抗体对于测烟草凝集素蛋白的特异性高,可以用于检测烟草凝集素蛋白,为烟草凝集素的检测提供了一种新的途径。In view of this, the present invention firstly provides a method for preparing an antibody capable of detecting tobacco lectin protein; the antibody prepared by the method has high specificity for detecting tobacco lectin protein, and can be used for detecting tobacco lectin protein, for The detection of tobacco lectins provides a new way.
本发明的技术方案如下:Technical scheme of the present invention is as follows:
一种可检测烟草凝集素蛋白的抗体的制备方法,其包含如下步骤:A method for preparing an antibody capable of detecting tobacco lectin protein, comprising the following steps:
乳剂1的制备步骤:取抗原、弗氏完全佐剂以及PBS(具体为0.01M的PBS)混合,制备成含抗原的乳剂1;Preparation steps of emulsion 1: mix antigen, Freund's complete adjuvant and PBS (specifically 0.01M PBS) to prepare antigen-containing emulsion 1;
乳剂2的制备步骤:取抗原、弗氏不完全佐剂以及PBS(具体为0.01M的PBS)混合,制备成含抗原的乳剂2;Preparation steps of emulsion 2: mix antigen, Freund's incomplete adjuvant and PBS (specifically 0.01M PBS) to prepare antigen-containing emulsion 2;
免疫步骤:所述的免疫步骤包括,将乳剂1注射至动物体内对动物进行第一次免疫;第一次免疫结束后,将乳剂2注射至动物体内对动物进行第二次免疫;第二次免疫结束后,将乳剂2注射至动物体内对动物进行第三次免疫;和/或第三次免疫结束后,将乳剂2注射至动物体内对动物进行第四次免疫;Immunization step: the immunization step includes injecting the emulsion 1 into the animal to immunize the animal for the first time; after the first immunization, injecting the emulsion 2 into the animal to immunize the animal for the second time; After the immunization, inject the emulsion 2 into the animal to immunize the animal for the third time; and/or after the third immunization, inject the emulsion 2 into the animal to immunize the animal for the fourth time;
抗体纯化步骤:取动物血清,从血清中纯化抗体,即得所述的可检测烟草凝集素蛋白的抗体;Antibody purification step: taking animal serum and purifying the antibody from the serum to obtain the antibody that can detect tobacco lectin protein;
其中,乳剂1和乳剂2中的抗原,其氨基酸序列如SEQ ID NO:1所示。Wherein, the amino acid sequence of the antigen in emulsion 1 and emulsion 2 is shown in SEQ ID NO: 1.
优选地,乳剂1的制备步骤中,抗原、弗氏完全佐剂以及PBS的用量比为300~500ug:1mL:1mL;Preferably, in the preparation step of emulsion 1, the dosage ratio of antigen, Freund's complete adjuvant and PBS is 300-500ug: 1mL: 1mL;
乳剂2的制备步骤中,抗原、弗氏不完全佐剂以及PBS的用量比为300~500ug:1mL:1mL。In the preparation step of emulsion 2, the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 300-500ug:1mL:1mL.
最优选地,乳剂1的制备步骤中,抗原、弗氏完全佐剂以及PBS的用量比为400ug:1mL:1mL。Most preferably, in the preparation step of emulsion 1, the dosage ratio of antigen, Freund's complete adjuvant and PBS is 400ug:1mL:1mL.
最优选地,乳剂2的制备步骤中,抗原、弗氏不完全佐剂以及PBS的用量比为400ug:1mL:1mL。Most preferably, in the preparation step of emulsion 2, the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 400ug:1mL:1mL.
优选地,第一次、第二次、第三次以及第四次免疫过程中,注射的抗原量为40~60ug。Preferably, during the first, second, third and fourth immunization process, the amount of injected antigen is 40-60ug.
最优选地,第一次、第二次、第三次以及第四次免疫过程中,注射的抗原量为50ug/只。Most preferably, during the first, second, third and fourth immunizations, the amount of injected antigen is 50ug/bird.
优选地,免疫步骤中所述的注射是指皮下注射。Preferably, the injection mentioned in the immunization step refers to subcutaneous injection.
优选地,免疫步骤中所述的动物为小鼠。Preferably, the animals in the immunization step are mice.
优选地,第一次免疫的时间为2~3周;第二次免疫的时间为2周;第三次免疫的时间为1周;第四次免疫的时间为1周。Preferably, the time for the first immunization is 2-3 weeks; the time for the second immunization is 2 weeks; the time for the third immunization is 1 week; the time for the fourth immunization is 1 week.
发明人经大量的试验研究表明:采用乳剂1和乳剂2对小鼠进行上述步骤的四次免疫,可以得到更高效价的可检测烟草凝集素蛋白的抗体。The inventors have shown through a large number of experimental studies that: using Emulsion 1 and Emulsion 2 to immunize mice with the above steps four times, higher titers of antibodies that can detect tobacco lectin protein can be obtained.
优选地,所述的抗体纯化步骤具体包括:Preferably, the antibody purification step specifically includes:
(1)用8~12倍柱体积的PBS缓冲液(具体为0.01M的PBS缓冲液)洗涤平衡层析柱(琼脂糖凝胶4B层析柱);(1) Wash the equilibrium chromatography column (Sepharose 4B chromatography column) with 8 to 12 times the column volume of PBS buffer (specifically 0.01M PBS buffer);
(2)将动物血清高速离心后的上清液与PBS缓冲液(具体为0.01M的PBS缓冲液)混合,然后加入到层析柱中;所述上清液与PBS缓冲液的体积比为1:1~2;(2) The supernatant after high-speed centrifugation of animal serum is mixed with PBS buffer (specifically 0.01M PBS buffer), and then added to the chromatography column; the volume ratio of the supernatant to PBS buffer is 1:1~2;
(3)用8~12倍柱体积的PBS缓冲液(具体为0.01M的PBS缓冲液)洗脱,至流出液无蛋白检出,关闭层析柱停止洗脱;(3) Elute with 8 to 12 times the column volume of PBS buffer (specifically 0.01M PBS buffer), until no protein is detected in the effluent, close the chromatography column to stop the elution;
(4)加入2~4倍柱体积的含柠檬酸的PBS缓冲液(具体为0.01M的PBS缓冲液)或含柠檬酸和甘氨酸组成的PBS缓冲液(具体为0.01M的PBS缓冲液),静置5~10min;接着进行洗脱,收集洗脱液,浓缩洗脱液冻干即得所述的可检测 烟草凝集素蛋白的抗体。(4) Add 2 to 4 times the column volume of PBS buffer containing citric acid (specifically 0.01M PBS buffer) or a PBS buffer containing citric acid and glycine (specifically 0.01M PBS buffer), Stand still for 5-10 minutes; then perform elution, collect the eluate, concentrate the eluate and freeze-dry to obtain the antibody that can detect tobacco lectin protein.
发明人经大量的研究表明:采用上述层析柱方法可以得到高纯度的可检测烟草凝集素蛋白的抗体。The inventors have shown through a large number of studies that: high-purity antibodies that can detect tobacco lectin protein can be obtained by using the above chromatography column method.
最优选地,步骤(3)中所述的含柠檬酸的PBS缓冲液是指含0.1M柠檬酸的PBS缓冲液;Most preferably, the PBS buffer containing citric acid described in step (3) refers to the PBS buffer containing 0.1M citric acid;
所述的含柠檬酸和甘氨酸组成的PBS缓冲液是指含0.7M柠檬酸和0.3M甘氨酸组成的PBS缓冲液。The PBS buffer solution containing citric acid and glycine refers to the PBS buffer solution containing 0.7M citric acid and 0.3M glycine.
发明人经大量的研究表明:PBS缓冲液的组成对于能否制备得到高纯度的可检测烟草凝集素蛋白的抗体起着至关重要的作用;当采用含0.1M柠檬酸的PBS缓冲液进行洗脱时,可以富集得到高纯度和高效价的可检测烟草凝集素蛋白的抗体。进一步研究表明:当采用含0.7M柠檬酸和0.3M甘氨酸组成的PBS缓冲液进行洗脱时,可以富集得到更高纯度和更高效价的可检测烟草凝集素蛋白的抗体。The inventors have shown through a large number of studies that: the composition of the PBS buffer plays a crucial role in the preparation of high-purity detectable tobacco lectin protein antibodies; when using PBS buffer containing 0.1M citric acid for washing When deactivated, high purity and high titer antibodies that can detect tobacco lectin protein can be obtained by enrichment. Further studies have shown that: when eluted with PBS buffer containing 0.7M citric acid and 0.3M glycine, antibodies that can detect tobacco lectin protein with higher purity and higher titer can be enriched.
本发明还提供一种由上述制备方法制备得到的可检测烟草凝集素蛋白的抗体。The present invention also provides an antibody capable of detecting tobacco lectin protein prepared by the above preparation method.
优选地,所述的可检测烟草凝集素蛋白的抗体具有SEQ ID NO:2或/和SEQ ID NO:3所述的氨基酸序列。Preferably, the antibody capable of detecting tobacco lectin protein has the amino acid sequence described in SEQ ID NO: 2 or/and SEQ ID NO: 3.
本发明还提供一种上述可检测烟草凝集素蛋白的抗体在检测烟草凝集素蛋白中的应用。The present invention also provides an application of the above-mentioned antibody capable of detecting tobacco lectin protein in detecting tobacco lectin protein.
有益效果:本发明首次制备得到了一种可检测烟草凝集素蛋白的抗体;该可检测烟草凝集素蛋白的抗体对于烟草凝集素蛋白具有较高的特异性;因此,可以将本发明所述的可检测烟草凝集素蛋白的抗体用于检测烟草凝集素蛋白;本发明所述的可检测烟草凝集素蛋白的抗体成功制备,为烟草凝集素蛋白的检测提供了一种新的检测途径;此外,采用本发明所述方法制备得到可检测烟草凝集素蛋白的抗体还具有较高的纯度以及效价;且该方法操作简单、制备成本低。Beneficial effects: the present invention prepares for the first time an antibody that can detect tobacco lectin protein; the antibody that can detect tobacco lectin protein has high specificity for tobacco lectin protein; therefore, the present invention can be used The antibody that can detect tobacco lectin protein is used to detect tobacco lectin protein; the antibody that can detect tobacco lectin protein according to the present invention is successfully prepared, which provides a new detection approach for the detection of tobacco lectin protein; in addition, The antibody capable of detecting tobacco lectin protein prepared by the method of the present invention also has high purity and titer; and the method is simple to operate and low in preparation cost.
以下结合实施例对本发明进行进一步解释,但实施例对本发明不做任何形式的限定。The present invention is further explained below in conjunction with the examples, but the examples do not limit the present invention in any form.
实施例1可检测烟草凝集素蛋白的抗体的制备Example 1 Preparation of an antibody capable of detecting tobacco lectin protein
(1)取抗原(其氨基酸序列如SEQ ID NO:1所示)、弗氏完全佐剂以及 PBS(具体为0.01M的PBS)混合,制备成含抗原的乳剂1;其中抗原、弗氏完全佐剂以及PBS的用量比为400ug:1mL:1mL;(1) Mix the antigen (the amino acid sequence of which is shown in SEQ ID NO: 1), Freund's complete adjuvant and PBS (specifically 0.01M PBS) to prepare antigen-containing emulsion 1; wherein the antigen, Freund's complete The dosage ratio of adjuvant and PBS is 400ug: 1mL: 1mL;
(2)取抗原(其氨基酸序列如SEQ ID NO:1所示)、弗氏不完全佐剂以及PBS(具体为0.01M的PBS)混合,制备成含抗原的乳剂2;其中,抗原、弗氏不完全佐剂以及PBS的用量比为400ug:1mL:1mL;(2) Take antigen (its amino acid sequence is as shown in SEQ ID NO: 1), Freund's incomplete adjuvant and PBS (specifically 0.01M PBS) are mixed, and are prepared into antigen-containing emulsion 2; wherein, antigen, Freund's The dosage ratio of Shi's incomplete adjuvant and PBS is 400ug: 1mL: 1mL;
(3)将乳剂1采用皮下注射的方式注射至Balb/c小鼠体内对Balb/c小鼠进行第一次免疫;第一次免疫结束后,将乳剂2采用皮下注射的方式注射至Balb/c小鼠体内对Balb/c小鼠进行第二次免疫;第二次免疫结束后,将乳剂2采用皮下注射的方式注射至Balb/c小鼠体内对动物进行第三次免疫;第三次免疫结束后,将乳剂2采用皮下注射的方式注射至Balb/c小鼠体内对动物进行第四次免疫;(3) Inject Emulsion 1 into Balb/c mice by subcutaneous injection to immunize Balb/c mice for the first time; after the first immunization, inject Emulsion 2 into Balb/c mice by subcutaneous injection. c mice to immunize Balb/c mice for the second time; after the second immunization, inject Emulsion 2 into Balb/c mice by subcutaneous injection to immunize the animals for the third time; After the immunization, the emulsion 2 was injected subcutaneously into the Balb/c mice to immunize the animals for the fourth time;
其中,第一次、第二次、第三次以及第四次免疫过程中,注射的抗原量为50ug/只;第一次免疫的时间为3周;第二次免疫的时间为2周;第三次免疫的时间为1周;第四次免疫的时间为1周;Among them, during the first, second, third and fourth immunizations, the amount of antigen injected was 50ug/monkey; the time of the first immunization was 3 weeks; the time of the second immunization was 2 weeks; The time for the third immunization is 1 week; the time for the fourth immunization is 1 week;
(5)取Balb/c小鼠血清,从血清中纯化抗体,即得所述的可检测烟草凝集素蛋白的抗体;从血清中纯化抗体的具体步骤如下:(5) Get the serum of Balb/c mice, and purify the antibody from the serum to obtain the antibody that can detect the tobacco lectin protein; the specific steps for purifying the antibody from the serum are as follows:
5.1)用10倍柱体积的PBS缓冲液(具体为0.01M的PBS缓冲液)洗涤平衡层析柱(具体为琼脂糖凝胶4B层析柱);5.1) Wash the equilibrium chromatography column (specifically Sepharose 4B chromatography column) with 10 times column volume of PBS buffer solution (specifically 0.01M PBS buffer solution);
5.2)将动物血清高速离心后的上清液与PBS缓冲液(具体为0.01M的PBS缓冲液)混合,然后加入到层析柱中;所述上清液与PBS缓冲液的体积比为1:1;5.2) The supernatant after high-speed centrifugation of animal serum is mixed with PBS buffer (specifically 0.01M PBS buffer), and then added to the chromatography column; the volume ratio of the supernatant to PBS buffer is 1 :1;
5.3)用10倍柱体积的PBS缓冲液(具体为0.01M的PBS缓冲液)洗脱,至流出液无蛋白检出,关闭层析柱停止洗脱;5.3) Elute with 10 times the column volume of PBS buffer (specifically 0.01M PBS buffer), until no protein is detected in the effluent, close the chromatography column to stop the elution;
5.4)加入2倍柱体积的含0.7M柠檬酸和0.3M甘氨酸组成的PBS缓冲液(具体为0.01M的PBS缓冲液),静置5min;接着进行洗脱,收集洗脱液,浓缩洗脱液冻干即得所述的可检测烟草凝集素蛋白的抗体。所述的可检测烟草凝集素蛋白的抗体具有SEQ ID NO:2所述的氨基酸序列。5.4) Add 2 times column volume of PBS buffer containing 0.7M citric acid and 0.3M glycine (specifically 0.01M PBS buffer), let stand for 5min; then perform elution, collect the eluate, concentrate and elute The antibody that can detect tobacco lectin protein can be obtained by lyophilizing the liquid. The antibody capable of detecting tobacco lectin protein has the amino acid sequence described in SEQ ID NO:2.
实施例2基本效价检测-间接ELSIAExample 2 Basic Potency Detection-Indirect ELSIA
(1)抗原包被:用包被液稀释抗原到指定浓度(无单独说明为1ug/ml),100μL/孔加入聚苯乙烯96孔反应板中,4℃放置过夜。(1) Antigen coating: Dilute the antigen with coating solution to the specified concentration (1ug/ml if not specified separately), add 100 μL/well into a polystyrene 96-well reaction plate, and place at 4°C overnight.
(2)洗涤:次日弃掉孔内的液体,洗涤液洗1次。(2) Washing: discard the liquid in the hole the next day, and wash once with the washing solution.
(3)封闭:加200μL/孔封闭液,37℃放置2h.(3) Blocking: add 200 μL/well blocking solution, and place at 37°C for 2 hours.
(4)洗涤:用洗涤液洗3次。(4) Washing: Wash 3 times with washing liquid.
(5)加待测样品(实施例1制备得到的抗体):以每孔100ul加入待测样(样品需要稀释的,按比例稀释好),温育1h。(5) Add the sample to be tested (the antibody prepared in Example 1): add the sample to be tested (if the sample needs to be diluted, it should be diluted in proportion) at 100 ul per well, and incubate for 1 h.
(6)洗涤:弃掉待测样品,用洗涤液洗3次。(6) Washing: Discard the sample to be tested, and wash 3 times with washing solution.
(7)加酶标二抗抗体:加入HRP标记羊抗鼠IgG(1:10000,酶稀稀释),100μl/孔,37℃孵育40min。(7) Add enzyme-labeled secondary antibody: add HRP-labeled goat anti-mouse IgG (1:10000, diluted with enzyme), 100 μl/well, and incubate at 37°C for 40 minutes.
(8)洗涤:用洗涤液洗5次。(8) Washing: wash 5 times with washing liquid.
(9)显色:加新鲜配制的底物溶液90μL/孔,37℃暗处放置15min(9) Color development: Add 90 μL/well of freshly prepared substrate solution, and place in the dark at 37°C for 15 minutes
(10)终止反应、比色:加50μL/孔终止液。颜色变黄;用酶标仪测定450nm处各孔的吸光值。(10) Stop reaction, colorimetry: add 50 μL/well stop solution. The color turns yellow; use a microplate reader to measure the absorbance of each well at 450 nm.
结果表明:待测样品测定孔中的吸光值>阴性对照孔均值3倍以上,这说明本发明制备得到的可检测烟草凝集素蛋白的抗体为阳性;且具有较高的效价。The results show that: the absorbance value in the measurement well of the test sample is more than 3 times the average value of the negative control well, which shows that the antibody prepared by the present invention that can detect the tobacco lectin protein is positive; and has a higher titer.
实施例3 Western Blot实验Embodiment 3 Western Blot experiment
(1)聚丙烯酰胺凝胶的制备(1) Preparation of polyacrylamide gel
1.1)配制浓度为15%的分离胶溶液:依次加入去离子水2.3ml、30%丙烯酰胺5ml、PH8.8的Tris 2.5ml、10%过硫酸铵100μL、10%SDS 100μL、TEMED6μL(加入TEMED后,分离胶马上开始聚合,故应立即快速混匀);1.1) Prepare a separating gel solution with a concentration of 15%: add 2.3ml of deionized water, 5ml of 30% acrylamide, 2.5ml of Tris with a pH of 8.8, 100μL of 10% ammonium persulfate, 100μL of 10% SDS, and 6μL of TEMED (add TEMED After that, the separating gel starts to polymerize immediately, so it should be mixed immediately and quickly);
1.2)迅速在两玻璃板的间隙中加入分离胶溶液,留出灌注浓缩胶所需空间,小心地在分离胶溶液上覆盖—层异丙醇;1.2) Quickly add the separating gel solution in the gap between the two glass plates, leave the space required for perfusion of the stacking gel, and carefully cover the separating gel solution with a layer of isopropanol;
1.3)分离胶聚合完全后,尽可能排去凝胶上的液体,再用纸巾的边缘吸净残留液体;1.3) After the separation gel is completely polymerized, drain the liquid on the gel as much as possible, and then use the edge of the paper towel to absorb the remaining liquid;
1.4)配制浓度为5%的浓缩胶溶液:依次加入去离子水2.7ml、30%丙烯酰胺670μL、PH8.8的Tris 500μL、10%过硫酸铵40μL、10%SDS 40μL、TEMED6μL(加入TEMED后,分离胶马上开始聚合,故应立即快速混匀);1.4) Prepare a stacking gel solution with a concentration of 5%: add 2.7ml of deionized water, 670μL of 30% acrylamide, 500μL of Tris with a pH of 8.8, 40μL of 10% ammonium persulfate, 40μL of 10% SDS, and 6μL of TEMED (after adding TEMED) , the separating gel starts to polymerize immediately, so it should be mixed immediately and quickly);
1.5)快速在已聚合的分离胶上直接灌注浓缩胶,立即在浓缩胶溶液中插入干净的梳子(小心避免混入气泡);1.5) Quickly pour stacking gel directly on the polymerized separating gel, and immediately insert a clean comb into the stacking gel solution (be careful to avoid mixing air bubbles);
1.26)浓缩胶聚合完全后,小心移出梳子,向电泳槽内加入蛋白质电泳缓冲液。1.26) After the stacking gel is completely polymerized, carefully remove the comb and add protein electrophoresis buffer into the electrophoresis tank.
2样品的制备2 Preparation of samples
2.1)细胞培养至10
7,收集细胞至15ml离心管,2000rpm离心5min,去上清;
2.1) Culture the cells to 10 7 , collect the cells into a 15ml centrifuge tube, centrifuge at 2000rpm for 5min, and remove the supernatant;
2.2)培养基洗两遍,2000rpm离心5min,去上清;2.2) The culture medium was washed twice, centrifuged at 2000rpm for 5min, and the supernatant was removed;
2.3)收集细胞后加入1mlPBS,0.1%NP40,冰上裂解10min;2.3) After collecting the cells, add 1ml PBS, 0.1% NP40, and lyse on ice for 10 minutes;
2.4)10000rpm离心5min,取上清,加入等体积2×loading buffer,沸水煮5min,分装后-20℃保存;2.4) Centrifuge at 10,000rpm for 5min, take the supernatant, add an equal volume of 2×loading buffer, cook in boiling water for 5min, and store at -20°C after aliquoting;
3电泳3 Electrophoresis
3.1)把需检测的实施例1制备得到的抗体样品(10μL)和2×(或者6×)loading buffer(10μL)混合,用移液枪慢慢将15μL混合物加至样品槽中,预染Maker一般加10μL;3.1) Mix the antibody sample (10 μL) prepared in Example 1 to be detected with 2× (or 6×) loading buffer (10 μL), slowly add 15 μL of the mixture to the sample tank with a pipette gun, and pre-stain the Maker Generally add 10μL;
3.2)打开电源,采用200V的电压,电泳直至溴酚蓝上样缓冲液在凝胶中迁移至凝胶底部;3.2) Turn on the power, use a voltage of 200V, and perform electrophoresis until the bromophenol blue loading buffer migrates to the bottom of the gel in the gel;
3.3)切断电源,取出凝胶,用R250考马斯亮蓝浸泡凝胶染色,沸水煮5min;3.3) Cut off the power, take out the gel, soak the gel with R250 Coomassie Brilliant Blue for staining, and cook in boiling water for 5 minutes;
3.4)取出染色的凝胶,用自来水浸泡凝胶脱色,沸水煮约20min,观察脱色后的蛋白质条带;3.4) Take out the stained gel, soak the gel in tap water for decolorization, boil it in boiling water for about 20 minutes, and observe the protein bands after decolorization;
4转膜4 transfer film
4.1)取胶后讲胶剪成适当大小并浸入转膜buffer中;4.1) After taking the glue, cut the glue into an appropriate size and immerse it in the transfer buffer;
4.2)将PVDF膜浸泡于甲醇1min后转入转膜buffer中,将滤纸也浸入转膜buffer中(PVDF膜和滤纸均剪成与胶相同大小);4.2) Soak the PVDF membrane in methanol for 1 min, then transfer it to the transfer buffer, and immerse the filter paper in the transfer buffer (both the PVDF membrane and the filter paper are cut to the same size as the glue);
4.3)用转膜buffer淋洗石墨电极,铺两张滤纸,滴少许转膜buffer;4.3) Rinse the graphite electrode with transfer buffer, spread two pieces of filter paper, and drop a little transfer buffer;
铺上膜,滴少许转膜buffer;铺上胶,再滴少许转膜buffer(注意不要产生气泡);Spread the film, drop a little transfer buffer; spread the glue, and then drop a little transfer buffer (be careful not to generate air bubbles);
4.4)最后铺两张滤纸,滴少许转膜buffer;4.4) Finally, spread two pieces of filter paper and drop a little transfer buffer;
4.5)盖上电极,电压调至最大,以1.5mA/cm2凝胶体积转膜1.5h(负载电压不宜超过1V/cm2);4.5) Cover the electrode, adjust the voltage to the maximum, and transfer the membrane with a gel volume of 1.5mA/cm2 for 1.5h (the load voltage should not exceed 1V/cm2);
5封闭5 closed
5.1)将膜取出,PBST洗三次,每次5min(水平摇床上震荡);5.1) Take out the membrane and wash it three times with PBST, each time for 5 minutes (shaking on a horizontal shaker);
5.2)将膜取出,浸没于封闭液中37℃,2h或4℃过夜(封闭液为1%酪蛋白或2%OVA)5.2) Take out the membrane and immerse in blocking solution at 37°C for 2 hours or overnight at 4°C (blocking solution is 1% casein or 2% OVA)
6结合抗体6 binding antibodies
6.1)将膜取出,PBST洗三次,每次5min(水平摇床上震荡);6.1) Take out the membrane and wash it three times with PBST, each time for 5 minutes (shaking on a horizontal shaker);
6.2)将膜取出,浸泡于用1%酪蛋白稀释的一抗稀释液中,37℃,1h(一般一抗稀释1:1000);6.2) Take out the membrane, soak it in primary antibody diluent diluted with 1% casein, 37°C, 1h (general primary antibody dilution 1:1000);
6.3)将膜取出,PBST洗三次,每次5min(水平摇床上震荡);6.3) Take out the membrane and wash it three times with PBST, each time for 5 minutes (shaking on a horizontal shaker);
6.4)将膜取出,浸泡于用1%酪蛋白稀释的二抗抗稀释液中,37℃,1h6.4) Take out the membrane, soak it in secondary antibody diluent diluted with 1% casein, 37°C, 1h
(羊抗小鼠-HRP 1:3000-1:5000,羊抗兔-HRP 1:15000);(goat anti-mouse-HRP 1:3000-1:5000, goat anti-rabbit-HRP 1:15000);
7曝光7 exposure
7.1)将A、B发光液等比例稀释混合(各500ml),将膜至于保鲜膜上,AB混合液均匀滴至膜上,盖上保鲜膜,静止1min;7.1) Dilute and mix A and B luminescent liquids in equal proportions (500ml each), place the film on the plastic wrap, drop the AB mixture evenly onto the film, cover with the plastic wrap, and let stand for 1 min;
7.2)打开保鲜膜,用滤纸吸干表面残留液体,至于保鲜膜内固定于暗盒中7.2) Open the plastic wrap, blot the residual liquid on the surface with filter paper, and fix the inside of the plastic wrap in the cassette
7.3)将暗盒至于暗室中,取出胶片迅速至于暗盒内膜上,关闭暗盒,根据所见荧光强度曝光(一般曝光时间为1min,若条带较弱可选择压片过夜);7.3) Put the cassette in the darkroom, take out the film and quickly place it on the inner membrane of the cassette, close the cassette, and expose according to the fluorescence intensity you see (the general exposure time is 1 min, if the band is weak, you can choose to press the film overnight);
7.4)打开暗盒,取出胶片立即完全侵入显影液中1min;7.4) Open the cartridge, take out the film and immediately immerse it in the developing solution for 1 min;
7.5)取出胶片,去离子水漂洗后侵入至定影液中1min;7.5) Take out the film, rinse it with deionized water and soak it in the fixer for 1 min;
7.6)取出胶片,去离子水漂洗后晾干,标定Marker,分析实验结果。7.6) Take out the film, rinse it with deionized water and dry it, calibrate the Marker, and analyze the experimental results.
结果表明:实施例1制备得到的抗体与烟草凝集素蛋白发生反应与空载体不发生反应,而空白对照组与烟草凝集素蛋白也不发生反应;这说明实施例1制备得到的抗体对烟草凝集素蛋白具有特异性。The results show that: the antibody prepared in Example 1 reacts with the tobacco lectin protein and does not react with the empty vector, and the blank control group does not react with the tobacco lectin protein; this shows that the antibody prepared in Example 1 has no effect on tobacco agglutinin. Proteins are specific.
尽管上面已经示出和描述了本发明的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本发明的限制;本领域技术人员对上述实施例进行变化、修改、替换和变型,均属于本发明要求保护的范围。Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are exemplary and should not be construed as limiting the present invention; those skilled in the art can change, modify, replace and Variations all belong to the protection scope of the present invention.
Claims (10)
- 一种可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,包含如下步骤:A method for preparing an antibody capable of detecting tobacco lectin protein, characterized in that it comprises the following steps:乳剂1的制备步骤:取抗原、弗氏完全佐剂以及PBS混合,制备成含抗原的乳剂1;The preparation steps of emulsion 1: take the antigen, Freund's complete adjuvant and PBS and mix to prepare the emulsion 1 containing the antigen;乳剂2的制备步骤:取抗原、弗氏不完全佐剂以及PBS混合,制备成含抗原的乳剂2;Preparation steps of emulsion 2: mix antigen, Freund's incomplete adjuvant and PBS to prepare antigen-containing emulsion 2;免疫步骤:所述的免疫步骤包括,将乳剂1注射至动物体内对动物进行第一次免疫;第一次免疫结束后,将乳剂2注射至动物体内对动物进行第二次免疫;第二次免疫结束后,将乳剂2注射至动物体内对动物进行第三次免疫;和/或第三次免疫结束后,将乳剂2注射至动物体内对动物进行第四次免疫;Immunization step: the immunization step includes injecting the emulsion 1 into the animal to immunize the animal for the first time; after the first immunization, injecting the emulsion 2 into the animal to immunize the animal for the second time; After the immunization, inject the emulsion 2 into the animal to immunize the animal for the third time; and/or after the third immunization, inject the emulsion 2 into the animal to immunize the animal for the fourth time;抗体纯化步骤:取动物血清,从血清中纯化抗体,即得所述的可检测烟草凝集素蛋白的抗体;Antibody purification step: taking animal serum and purifying the antibody from the serum to obtain the antibody that can detect tobacco lectin protein;其中,乳剂1和乳剂2中的抗原,其氨基酸序列如SEQ ID NO:1所示。Wherein, the amino acid sequence of the antigen in emulsion 1 and emulsion 2 is shown in SEQ ID NO: 1.
- 根据权利要求1所述的可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,The method for preparing an antibody capable of detecting tobacco lectin protein according to claim 1, characterized in that,乳剂1的制备步骤中,抗原、弗氏完全佐剂以及PBS的用量比为300~500ug:1mL:1mL;In the preparation step of emulsion 1, the dosage ratio of antigen, Freund's complete adjuvant and PBS is 300-500ug: 1mL: 1mL;乳剂2的制备步骤中,抗原、弗氏不完全佐剂以及PBS的用量比为300~500ug:1mL:1mL;In the preparation step of emulsion 2, the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 300-500ug: 1mL: 1mL;最优选地,乳剂1的制备步骤中,抗原、弗氏完全佐剂以及PBS的用量比为400ug:1mL:1mL;Most preferably, in the preparation step of emulsion 1, the dosage ratio of antigen, Freund's complete adjuvant and PBS is 400ug: 1mL: 1mL;最优选地,乳剂2的制备步骤中,抗原、弗氏不完全佐剂以及PBS的用量比为400ug:1mL:1mL。Most preferably, in the preparation step of emulsion 2, the dosage ratio of antigen, Freund's incomplete adjuvant and PBS is 400ug:1mL:1mL.
- 根据权利要求1所述的可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,第一次、第二次、第三次以及第四次免疫过程中,注射的抗原量为40~60ug;The preparation method of an antibody capable of detecting tobacco lectin protein according to claim 1, characterized in that, in the first, second, third and fourth immunization process, the amount of injected antigen is 40-60ug ;最优选地,第一次、第二次、第三次以及第四次免疫过程中,注射的抗原量为50ug/只。Most preferably, during the first, second, third and fourth immunizations, the amount of injected antigen is 50ug/bird.
- 根据权利要求1所述的可检测烟草凝集素蛋白的抗体的制备方法,其特 征在于,免疫步骤中所述的注射是指皮下注射;免疫步骤中所述的动物为小鼠。The method for preparing an antibody capable of detecting tobacco lectin protein according to claim 1, wherein the injection described in the immunization step refers to subcutaneous injection; the animal described in the immunization step is a mouse.
- 根据权利要求1所述的可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,第一次免疫的时间为2~3周;第二次免疫的时间为2周;第三次免疫的时间为1周;第四次免疫的时间为1周。The preparation method of an antibody capable of detecting tobacco lectin protein according to claim 1, wherein the time of the first immunization is 2 to 3 weeks; the time of the second immunization is 2 weeks; the time of the third immunization is 2 weeks; The time is 1 week; the time of the fourth immunization is 1 week.
- 根据权利要求1所述的可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,所述的抗体纯化步骤具体包括:The method for preparing an antibody capable of detecting tobacco lectin protein according to claim 1, wherein the antibody purification step specifically comprises:(1)用8~12倍柱体积的PBS缓冲液洗涤平衡层析柱;(1) Wash the equilibrium chromatography column with PBS buffer solution of 8 to 12 times the column volume;(2)将动物血清高速离心后的上清液与PBS缓冲液混合,然后加入到层析柱中;所述上清液与PBS缓冲液的体积比为1:1~2;(2) The supernatant after high-speed centrifugation of animal serum is mixed with PBS buffer, and then added to the chromatography column; the volume ratio of the supernatant to PBS buffer is 1:1-2;(3)用8~12倍柱体积的PBS缓冲液洗脱,至流出液无蛋白检出,关闭层析柱停止洗脱;(3) Elute with 8-12 times the column volume of PBS buffer until no protein is detected in the effluent, close the chromatography column to stop the elution;(4)加入2~4倍柱体积的含柠檬酸的PBS缓冲液或含柠檬酸和甘氨酸组成的PBS缓冲液,静置5~10min;接着进行洗脱,收集洗脱液,浓缩洗脱液冻干即得所述的可检测烟草凝集素蛋白的抗体。(4) Add 2 to 4 times the column volume of PBS buffer containing citric acid or PBS buffer containing citric acid and glycine, and let it stand for 5 to 10 minutes; then perform elution, collect the eluate, and concentrate the eluate The antibody that can detect tobacco lectin protein can be obtained by freeze-drying.
- 根据权利要求6所述的可检测烟草凝集素蛋白的抗体的制备方法,其特征在于,步骤(3)中所述的含柠檬酸的PBS缓冲液是指含0.1M柠檬酸的PBS缓冲液;The preparation method of an antibody capable of detecting tobacco lectin protein according to claim 6, characterized in that the PBS buffer containing citric acid described in step (3) refers to the PBS buffer containing 0.1M citric acid;所述的含柠檬酸和甘氨酸组成的PBS缓冲液是指含0.7M柠檬酸和0.3M甘氨酸组成的PBS缓冲液。The PBS buffer solution containing citric acid and glycine refers to the PBS buffer solution containing 0.7M citric acid and 0.3M glycine.
- 权利要求1~7任一项所述的制备方法制备得到的可检测烟草凝集素蛋白的抗体。The antibody capable of detecting tobacco lectin protein prepared by the preparation method according to any one of claims 1 to 7.
- 根据权利要求8所述的可检测烟草凝集素蛋白的抗体,其特征在于,所述的可检测烟草凝集素蛋白的抗体具有SEQ ID NO:2或/和SEQ ID NO:3所述的氨基酸序列。The antibody capable of detecting tobacco lectin protein according to claim 8, wherein the antibody capable of detecting tobacco lectin protein has the amino acid sequence described in SEQ ID NO: 2 or/and SEQ ID NO: 3 .
- 权利要求8所述的可检测烟草凝集素蛋白的抗体在检测烟草凝集素蛋白中的应用。The use of the antibody capable of detecting tobacco lectin protein according to claim 8 in detecting tobacco lectin protein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110898359.5A CN113603772B (en) | 2021-08-05 | 2021-08-05 | Antibody capable of detecting tobacco lectin protein, and preparation method and application thereof |
CN202110898359.5 | 2021-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023010682A1 true WO2023010682A1 (en) | 2023-02-09 |
Family
ID=78307222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/123450 WO2023010682A1 (en) | 2021-08-05 | 2021-10-13 | Antibody capable of detecting nicotiana tabacum agglutinin protein, preparation method therefor and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113603772B (en) |
WO (1) | WO2023010682A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101985475A (en) * | 2009-07-28 | 2011-03-16 | 复旦大学附属华山医院 | Novel polyclonal antibody of secretive peptide INM02 and preparation method and use thereof |
CN104861059A (en) * | 2015-04-29 | 2015-08-26 | 中国计量学院 | Brown planthopper VgR polypeptide and multi-resistant preparation method thereof |
CN106432453A (en) * | 2016-08-23 | 2017-02-22 | 广东省农业科学院作物研究所 | Tobacco lectin protein and encoding gene thereof and application |
CN109897090A (en) * | 2018-12-24 | 2019-06-18 | 中国计量大学 | A kind of brown paddy plant hopper Vg polypeptide and its how anti-preparation method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020051397A1 (en) * | 2018-09-06 | 2020-03-12 | Academia Sinica | Antiviral lectin and uses thereof |
GB201903244D0 (en) * | 2019-03-14 | 2019-04-24 | Syndermix Ag | Methods for lectin production with improved yield |
CN110938120B (en) * | 2019-12-04 | 2021-12-03 | 中国农业科学院农业基因组研究所 | StSCI protein for changing self-incompatibility of diploid potato material |
-
2021
- 2021-08-05 CN CN202110898359.5A patent/CN113603772B/en active Active
- 2021-10-13 WO PCT/CN2021/123450 patent/WO2023010682A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101985475A (en) * | 2009-07-28 | 2011-03-16 | 复旦大学附属华山医院 | Novel polyclonal antibody of secretive peptide INM02 and preparation method and use thereof |
CN104861059A (en) * | 2015-04-29 | 2015-08-26 | 中国计量学院 | Brown planthopper VgR polypeptide and multi-resistant preparation method thereof |
CN106432453A (en) * | 2016-08-23 | 2017-02-22 | 广东省农业科学院作物研究所 | Tobacco lectin protein and encoding gene thereof and application |
CN109897090A (en) * | 2018-12-24 | 2019-06-18 | 中国计量大学 | A kind of brown paddy plant hopper Vg polypeptide and its how anti-preparation method |
Non-Patent Citations (1)
Title |
---|
LANNOO N., PEUMANS W., DAMME E.: "The presence of jasmonate-inducible lectin genes in some but not all Nicotiana species explains a marked intragenus difference in plant responses to hormone treatment", JOURNAL OF EXPERIMENTAL BOTANY, vol. 57, no. 12, GB , pages 3145 - 3155, XP093031812, ISSN: 0022-0957, DOI: 10.1093/jxb/erl076 * |
Also Published As
Publication number | Publication date |
---|---|
CN113603772B (en) | 2023-08-04 |
CN113603772A (en) | 2021-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110068688B (en) | Lactoferrin competition method nanoflower immunity detection flow chromatography detection card in cow's milk | |
CN105891491A (en) | Kit and application thereof | |
CN112759629A (en) | ELISA kit for detecting iridovirus antibody of micropterus salmoides and detection method thereof | |
CN113461782B (en) | Malachite green antigen mimic epitope, preparation method and application thereof | |
Vejtorp | Enzyme‐linked immunosorbent assay for determination of rubella IgG antibodies | |
CN109852588B (en) | Monoclonal antibody of anti-tilapia immune globulin IgM, cell strain and application thereof | |
WO2023010682A1 (en) | Antibody capable of detecting nicotiana tabacum agglutinin protein, preparation method therefor and application thereof | |
CN117187069B (en) | Escherichia coli HCP detection method for alkaline hydrolysis process | |
CN110627872A (en) | Phage display polypeptide specifically bound by imidacloprid antibody and application thereof | |
CN106565842A (en) | Universal polyclonal antibody of freshwater fish as well as preparation method and application of the universal polyclonal antibody | |
CN117624354A (en) | Anti-human acetylated tau281 rabbit monoclonal antibody and application thereof | |
CN109182281A (en) | Handle the method and kit of adeno-associated virus | |
CN113354716A (en) | Mouse norovirus recombinant antigen, monoclonal antibody and virus detection test strip | |
CN107855115B (en) | Affinity chromatographic column, preparation method and application | |
CN113564173B (en) | Recombinant adeno-associated virus rAAV aptamer and application thereof | |
CN113025580B (en) | Hybridoma cell strain, anti-fipronil monoclonal antibody produced by hybridoma cell strain and application of anti-fipronil monoclonal antibody | |
CN111273041B (en) | ELISA kit for detecting phalloidin and preparation and application thereof | |
CN110885793B (en) | Hybridoma cell strain secreting anti-cotinine monoclonal antibody, anti-cotinine monoclonal antibody and application of anti-cotinine monoclonal antibody | |
Cundiff et al. | Immunological determination of the relationship between large and small sizes of phytochrome | |
CN111707821A (en) | Colloidal gold test paper for detecting IBV (infectious bronchitis Virus) and preparation method thereof | |
Rouze et al. | Use of liposomes for the transfer of nucleic acids: Optimization of the method for tobacco mesophyll protoplasts with tobacco mosaic virus RNA | |
Tsutsui et al. | Immunofluorescent study of histone fractions F1 and F2a-1 in cultured cells | |
CN106610431A (en) | Enzyme-linked immunosorbent assay kit for detecting Benalaxyl and detection method thereof | |
Comoglio et al. | Tumor‐specific and tumor‐associated membrane antigens of rous sarcoma virus transformed hamster fibroblasts | |
CN108196045B (en) | Hybridoma cell strain, malachite green resistant monoclonal antibody, malachite green detection method, application and product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21952549 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |